Trial Profile
Randomized Clinical Trial to Evaluate the Use of Liraglutide in Individuals With Brain Death and Anti-inflammatory and Anti-apoptotic Effects on Organs to be Transplanted
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Mar 2024
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Inflammation
- Focus Therapeutic Use
- 01 Mar 2024 Status changed from recruiting to completed.
- 25 Sep 2018 New trial record